LASERFLO BPM2

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 1997-03-17 for LASERFLO BPM2 manufactured by Vasamedics L.l.c..

Event Text Entries

[21397009] On 2/11/97 the blood perfusion monitor was used post operatively to measure blood flow on a muscle flap transplant on a 39 yr old male pt. The muscle flap failed yet the monitor indicated some blood flow. The monitor was tested at the plastic surgery lab immediately after the case with no trouble found. The monitor has not yet been returned to the mfr for eval.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2183929-1997-00001
MDR Report Key76826
Date Received1997-03-17
Date of Report1997-03-10
Date of Event1997-02-11
Date Mfgr Received1997-02-14
Device Manufacturer Date1991-07-01
Date Added to Maude1997-03-20
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Remedial ActionIN
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameLASERFLO
Generic NameLASER DOPPLER BLOOD FLOW MONITOR
Product CodeDPW
Date Received1997-03-17
Model NumberBPM2
Catalog NumberBPM2
Lot NumberNA
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device Availability*
Device Age*
Device Eval'ed by MfgrR
Implant FlagN
Date RemovedA
Device Sequence No1
Device Event Key76548
ManufacturerVASAMEDICS L.L.C.
Manufacturer Address2963 YORKTON BLVD. ST PAUL MN 55117 US
Baseline Brand NameLASERFLO BLOOD PERFUSION MONITORING SYSTEM
Baseline Generic NameLASER DOPPLER BLOOD PERFUSION MONITORING SYSTEM
Baseline Model NoBPM2
Baseline Catalog NoBPM2
Baseline IDBPM2 MONITOR AN
Baseline Device FamilyLASER DOPPLER BLOOD PERFUSION MONITORING SYSTEM
Baseline Shelf Life ContainedN
Baseline PMA FlagN
Baseline 510K PMNY
Premarket NotificationK912446
Baseline PreamendmentN
Baseline TransitionalN
510k ExemptN


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization; 2. Other 1997-03-17

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.